Journal Article Summary
The article investigates whether body weight influences the effectiveness of low-dose aspirin in preventing cardiovascular events in older adults. This topic is significant because previous research suggested that the protective effects of aspirin might vary based on body weight, particularly in individuals weighing less than 70 kg. Given the limited representation of older adults in earlier studies, this research aims to clarify the relationship between body weight and aspirin's efficacy in a larger, more diverse population of older men and women.
The study analyzed data from the ASPREE trial, which included over 19,000 participants aged 70 and older, who were randomly assigned to receive either 100 mg of aspirin or a placebo. Researchers collected information on participants' body weight, height, and other measurements to assess their body composition. The findings revealed that body weight did not affect aspirin's ability to prevent cardiovascular events. However, there was an increased risk of major bleeding associated with aspirin use in heavier men, indicating that aspirin's safety profile may vary with body weight, but its effectiveness does not.
Despite the comprehensive nature of the study, there are limitations to consider. The research primarily focused on older adults, and the results may not apply to younger populations or those with chronic illnesses. Patients should discuss their individual risks and benefits of aspirin therapy with their healthcare providers, especially if they have concerns about body weight and bleeding risks. This conversation is crucial for making informed decisions about aspirin use for cardiovascular health.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Woods Robyn L, Polekhina Galina, Wolfe Rory, Nelson Mark R., Ernst Michael E., Reid Christopher M., Shah Raj C., Lockery Jessica E., et al.. No modulation of aspirin’s effect by body weight in healthy older men and women. Circulation 2020. DOI: 10.1161/CIRCULATIONAHA.119.044142. PMID: 32223674. PMCID: PMC7286412.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
